Queen's University

Professor Lesley Seymour is the Director of the Investigational New Drug Program as well as Compliance and is the Deputy Director of the Canadian Clinical Trials Group. She is a Professor of Oncology at Queens University, Kingston Ontario. She completed specialist training in Internal Medicine and later Clinical Haematology and Medical Oncology as well as a PhD in translational biology (breast cancer).  After positions as Senior Consultants in Clinical Haematology and Medical Oncology, she spent two years in the pharmaceutical industry, and then relocated to Canada as the Director of Medical Oncology in Newfoundland before taking up her current role at CCTG. She is the principal investigator and co-investigator on numerous grants for clinical research and training.

Dr Seymour has served on many provincial, national and international committees, editorial boards, review and grants panels, including the National Cancer Institute, American Society of Clinical Oncology, Journal of Clinical Oncology and Health Canada, and has served on the faculty of FLIMS and ACORD.